Literature DB >> 10803605

High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors.

M Allen1, J Reeves, G Mellor.   

Abstract

High throughput fluorescence polarization (FP) assays are described that offer a nonradioactive, homogeneous, and low-cost alternative to radioligand binding assays for cell surface receptors (G protein-coupled receptors and ligand-gated ion channels). FP assays were shown to work across a range of both peptide (vasopressin V1a and delta-opioid) and nonpeptide (beta1-adrenoceptor, 5-hydroxytryptamine3) receptors. Structure-activity relationships were investigated at beta1-receptors and were found to be consistent with radioligand binding assays. FP was shown to tolerate up to 5% DMSO with no loss in sensitivity or signal window. From a random set of 1,280 compounds, 1.9% were found to significantly interfere with FP measurement. If fluorescent or quenching compounds were eliminated (3% of all compounds), less than 0.4% of compounds were found to interfere with FP measurement. Assays could be run in 384-well plates with little loss of signal window or sensitivity compared to 96-well plate assays. New advances in FP measurement have therefore enabled FP to offer a high throughput alternative to radioligand binding for cell surface receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803605     DOI: 10.1177/108705710000500202

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  16 in total

1.  Novel Alexa Fluor-488 labeled antagonist of the A(2A) adenosine receptor: Application to a fluorescence polarization-based receptor binding assay.

Authors:  Miklós Kecskés; T Santhosh Kumar; Lena Yoo; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2010-05-11       Impact factor: 5.858

Review 2.  High throughput screening in drug discovery.

Authors:  A Carnero
Journal:  Clin Transl Oncol       Date:  2006-07       Impact factor: 3.405

Review 3.  Cell-based assays for high-throughput screening.

Authors:  W Frank An; Nicola Tolliday
Journal:  Mol Biotechnol       Date:  2010-06       Impact factor: 2.695

4.  Discovery of Fluorescence Polarization Probe for the ELISA-Based Antagonist Screening of α1-Adrenergic Receptors.

Authors:  Zhao Ma; Zhenzhen Liu; Tianyu Jiang; Tianchao Zhang; Huateng Zhang; Lupei Du; Minyong Li
Journal:  ACS Med Chem Lett       Date:  2016-08-26       Impact factor: 4.345

5.  Creating and virtually screening databases of fluorescently-labelled compounds for the discovery of target-specific molecular probes.

Authors:  Rhiannon L Kamstra; Saedeh Dadgar; John Wigg; Morshed A Chowdhury; Christopher P Phenix; Wely B Floriano
Journal:  J Comput Aided Mol Des       Date:  2014-08-24       Impact factor: 3.686

6.  Identification of 2-oxohistidine Interacting Proteins Using E. coli Proteome Chips.

Authors:  Jun-Mu Lin; Yu-Ting Tsai; Yu-Hsuan Liu; Yun Lin; Hwan-Ching Tai; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2016-09-19       Impact factor: 5.911

7.  Fluorescence polarization assays in small molecule screening.

Authors:  Wendy A Lea; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2011-01       Impact factor: 6.098

8.  Quantitative comparison of functional screening by measuring intracellular Ca2+ with radioligand binding at recombinant human dopamine receptors.

Authors:  Matthias U Kassack
Journal:  AAPS PharmSci       Date:  2002

Review 9.  Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assays and receptor studies.

Authors:  B Mouillac; M Manning; T Durroux
Journal:  Mini Rev Med Chem       Date:  2008-09       Impact factor: 3.862

Review 10.  Fluorescence anisotropy imaging in drug discovery.

Authors:  Claudio Vinegoni; Paolo Fumene Feruglio; Ignacy Gryczynski; Ralph Mazitschek; Ralph Weissleder
Journal:  Adv Drug Deliv Rev       Date:  2018-02-02       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.